Evidence map›Paper›PMID 36494580›Full record

ArticleCancer gene therapy2023

Pals1 functions in redundancy with SMAP1 to inhibit Arf6 in order to prevent Rac1-dependent colorectal cancer cell migration and invasion.

Julia Harms, Simona Mareike Lüttgenau, Christin Emming, Justine Guske, Katrin Weber, Thomas Wagner, Larissa Schowe, Pavel Nedvetsky, Michael P Krahn

Open access · hybridFull text read
In one paragraph

Article in Cancer gene therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Julia HarmsMedical Clinic D, Medical Cell Biology, University Hospital of Münster, Münster, Germany.
Simona Mareike LüttgenauMedical Clinic D, Medical Cell Biology, University Hospital of Münster, Münster, Germany.
Christin EmmingMedical Clinic D, Medical Cell Biology, University Hospital of Münster, Münster, Germany.ORCID 0000-0001-5793-5905
Justine GuskeMedical Clinic D, Medical Cell Biology, University Hospital of Münster, Münster, Germany.
Katrin WeberMedical Clinic D, Medical Cell Biology, University Hospital of Münster, Münster, Germany.
Thomas WagnerMedical Clinic D, Medical Cell Biology, University Hospital of Münster, Münster, Germany.
Larissa SchoweMedical Clinic D, Medical Cell Biology, University Hospital of Münster, Münster, Germany.
Pavel NedvetskyMedical Clinic D, Medical Cell Biology, University Hospital of Münster, Münster, Germany.
Michael P KrahnMedical Clinic D, Medical Cell Biology, University Hospital of Münster, Münster, Germany. Michael.Krahn@uni-muenster.de.ORCID 0000-0001-7718-9890
University Hospital Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Downregulation of cell-cell adhesion and increased motility are prerequisites for the metastasis of cancer cells. We have recently shown that downregulation of the tight junction adapter protein Pals1 in colorectal cancer cells results in an increase of cell migration, invasion, and metastasis due to the enhanced activation of Arf6 and Rac1. We now reveal a redundancy between the Arf6-GAP SMAP1 and Pals1 in regulating Arf6 activity and thereby Rac1-dependent cell migration. The gene encoding SMAP1 is frequently disrupted in microsatellite instable colorectal cancer specimen and cell lines. In cells expressing SMAP1, deletion of Pals1 leads to disturbed formation of tight junctions but has no impact on Arf6 activity and cell migration. In contrast, inactivation of both SMAP1 and Pals1 results in enhanced Arf6/Rac1 activity and increased cell migration and invasion. Furthermore, analyzing patient cohorts, we found a significant decrease in patient's survival when both genes were downregulated, in contrast to cases, when expression of only one of both genes was affected. Taken together, we identified a redundancy between SMAP1 and Pals1 in the regulation of activation of Arf6/Rac1, thereby controlling cell migration, invasion, and metastasis of colorectal cancer cells.

Indexed as

ADP-Ribosylation FactorsColorectal NeoplasmsCell LineCell MovementGTPase-Activating ProteinsHumansMembrane ProteinsNucleoside-Phosphate Kinaserac1 GTP-Binding ProteinADP-Ribosylation FactorsGTPase-Activating ProteinsMembrane ProteinsMPP5 protein, humanNucleoside-Phosphate Kinaserac1 GTP-Binding ProteinRAC1 protein, humanSMAP1 protein, human

Identifiers

PMID36494580
PMCPMC10014575
OpenAlexW4311019340

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read38
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.